Unknown

Dataset Information

0

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.

ABSTRACT: Aging is a heterogeneous process. Most newly diagnosed cancers occur in older adults, and it is important to understand a patient's underlying health status when making treatment decisions. A geriatric assessment provides a detailed evaluation of medical, psychosocial, and functional problems in older patients with cancer. Specifically, it can identify areas of vulnerability, predict survival and toxicity, assist in clinical treatment decisions, and guide interventions in routine oncology practice; however, the uptake is hampered by limitations in both time and resources, as well as by a lack of expert interpretation. In this review, we describe the utility of geriatric assessment by using an illustrative case and provide a practical approach to geriatric assessment in oncology.

SUBMITTER: Loh KP 

PROVIDER: S-EPMC5812308 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

What Every Oncologist Should Know About Geriatric Assessment for Older Patients With Cancer: Young International Society of Geriatric Oncology Position Paper.

Loh Kah Poh KP   Soto-Perez-de-Celis Enrique E   Hsu Tina T   de Glas Nienke A NA   Battisti Nicolò Matteo Luca NML   Baldini Capucine C   Rodrigues Manuel M   Lichtman Stuart M SM   Wildiers Hans H  

Journal of oncology practice 20180201 2

Aging is a heterogeneous process. Most newly diagnosed cancers occur in older adults, and it is important to understand a patient's underlying health status when making treatment decisions. A geriatric assessment provides a detailed evaluation of medical, psychosocial, and functional problems in older patients with cancer. Specifically, it can identify areas of vulnerability, predict survival and toxicity, assist in clinical treatment decisions, and guide interventions in routine oncology practi  ...[more]

Similar Datasets

Unknown Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper.
| S-EPMC7492214 | biostudies-literature
Unknown Geriatric assessment in older adults with non-Hodgkin lymphoma: A Young International Society of Geriatric Oncology (YSIOG) review paper.
| S-EPMC9232919 | biostudies-literature
Unknown Immunotherapy and targeted therapies in older patients with advanced melanoma; Young International Society of Geriatric Oncology review paper.
| S-EPMC8074511 | biostudies-literature
Unknown Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.
| S-EPMC7188597 | biostudies-literature
Unknown COVID-19 vaccines in older adults with cancer: a Young International Society of Geriatric Oncology perspective.
| S-EPMC8102034 | biostudies-literature
Unknown Transplant-ineligible newly diagnosed multiple myeloma: Current and future approaches to clinical care: A Young International Society of Geriatric Oncology Review Paper.
| S-EPMC8113071 | biostudies-literature
Unknown Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review paper.
| S-EPMC6249663 | biostudies-literature
Unknown Chemotherapy and gene expression profiling in older early luminal breast cancer patients: An International Society of Geriatric Oncology systematic review.
| S-EPMC10861271 | biostudies-literature
Unknown Hypomethylating agent-based therapies in older adults with acute myeloid leukemia - A joint review by the Young International Society of Geriatric Oncology and European Society for Blood and Marrow Transplantation Trainee Committee.
| S-EPMC10106360 | biostudies-literature
Unknown Reply to 'Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'.
| S-EPMC5663272 | biostudies-literature